APA (7th ed.) Citation

Sokolenko, A. P., Gorodnova, T. V., Bizin, I. V., Kuligina, E. S., Kotiv, K. B., Romanko, A. A., . . . Imyanitov, E. N. (2021). Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients. Cancer Chemotherapy & Pharmacology, 88(3), 439. https://doi.org/10.1007/s00280-021-04301-6

Chicago Style (17th ed.) Citation

Sokolenko, Anna P., et al. "Molecular Predictors of the Outcome of Paclitaxel Plus Carboplatin Neoadjuvant Therapy in High-grade Serous Ovarian Cancer Patients." Cancer Chemotherapy & Pharmacology 88, no. 3 (2021): 439. https://doi.org/10.1007/s00280-021-04301-6.

MLA (9th ed.) Citation

Sokolenko, Anna P., et al. "Molecular Predictors of the Outcome of Paclitaxel Plus Carboplatin Neoadjuvant Therapy in High-grade Serous Ovarian Cancer Patients." Cancer Chemotherapy & Pharmacology, vol. 88, no. 3, 2021, p. 439, https://doi.org/10.1007/s00280-021-04301-6.